Effectiveness and Cost-effectiveness of the Check Your Health Preventive Programme

Sponsor
University of Aarhus (Other)
Overall Status
Unknown status
CT.gov ID
NCT02028195
Collaborator
Tryg Danmark (Other), Randers Municipality, Denmark (Other), Region MidtJylland Denmark (Other)
11,000
1
2
79
139.2

Study Details

Study Description

Brief Summary

Check your health is a prevention intervention designed to create awareness and action on health condition with focus at physical activity at a population-level to 30-49 years of age. It consists of a behavioural and clinical examination followed by either (I) referral to a health promoting consultation in general practice (II) targeted behavioural programmes at the local Health Centre or (III ) no need for follow-up; stratified after risk-profile. The CORE trial (Check your health) aim to investigate effectiveness on health and social outcomes of the preventive health check and to establish the cost-effectiveness according to life years gained; direct costs and total health costs. A pragmatic cluster randomised controlled trial has been established to meet the aims and in total 10.600 individuals from 35 practices have been randomized in to two groups that will be invited in 2013-14 and 2017-18 respectively. The group offered the preventive health check in 2013-14 will constitute the intervention group and the group examined in 2017 - 18 the control group. A follow up of the intervention group in 2017 - 18 will provide data for the intention to treat analysis revealing the effect. Outcome measures are level of physical activity, risk of getting cardiovascular disease, sick leave and labor market attachment.

Condition or Disease Intervention/Treatment Phase
  • Other: Health check
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
11000 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
The CORE-trial: a Pragmatic Randomized Controlled Trial in Primary Care Investigating Effectiveness and Cost-effectiveness of the Check Your Health Preventive Programme Offered Population-wide to 30-49 Years
Study Start Date :
May 1, 2013
Anticipated Primary Completion Date :
Dec 1, 2018
Anticipated Study Completion Date :
Dec 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Health check

The intervention consists of invitation for a behavioural and clinical examination followed by either (I) referral to a health promoting consultation in general practice (II) targeted behavioural programmes at the local Health Centre or (III ) no need for follow-up.

Other: Health check
The program includes four components: Invitation: All participants receive invitation by mail and a prefixed appointment time. A web-based questionnaire including self-reported health (SF12), physical activity, smoking habits and alcohol use/behaviour has to be answered before Health Examination (HE). The HE include: Blood pressure, waist, weight, lung function test, lipid profile, HbA1c and fitness (Aastrand). Health profile pamphlet: The participant receives a pamphlet with the results. The persons are stratified into three groups (I) referral to a consultation in general practice (GP) (II) targeted behavioural programs at the health centre (HC) or (III ) no identified need for health promoting follow-up. Follow-up according to risk-profile: If referred to GP treatment of risk conditions or diseases will follow national guidelines. The GPs were paid 50 Euros per health interview.

No Intervention: No invitation

The persons randomised to the control arm does not get invitation to a health care examination before time for follow up in the intervention group.

Outcome Measures

Primary Outcome Measures

  1. Physical activity [4 years]

    Physical activity level will be measured by 1) self-reported physical activity (days/week with minimum 30 minutes moderate physical activity) and 2) physical fitness, measured by Aastrands submaximal bike-test.

  2. Modelled cardiovascular risk [4 years]

    Cardiovascular risk will be measured as a modelled risk of developing cardiovascular disease within 10 years and includes information on age, gender, smoking status, systolic blood pressure and total cholesterol.

  3. Health related quality of life [4 years]

    Health related quality of life measured by The Medical Outcome Study Short Form 12 Health Survey (SF12)

  4. Functional capacity [4 years]

    Functional capacity will be measured as affiliation to the labor market (work participation in the last year)and sick leave > 3 weeks.

Other Outcome Measures

  1. Health economy assessment [4 years]

    The economic benefits of the interventions will be assessed by comparing mean direct and total costs (direct and productivity costs), and expected life years gained (LYG) in the intervention group with the control group (within a period of four.

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 49 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • all citizens living in Randers Municipality aged 30-49 on 1 January 2012, identified in the Danish Civil Registers (DCR) and randomised for health check in 2013 or 2017.
Exclusion Criteria:
  • Terminal illness, reported by their GP is exclusion criteria for receiving invitation.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Public Health Aarhus Denmark 8000

Sponsors and Collaborators

  • University of Aarhus
  • Tryg Danmark
  • Randers Municipality, Denmark
  • Region MidtJylland Denmark

Investigators

  • Principal Investigator: Annelli Sandbæk, Professor, University of Aarhus
  • Principal Investigator: Helle T Maindal, Professor, University of Aarhus

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Annelli Sandbæk, Professor, University of Aarhus
ClinicalTrials.gov Identifier:
NCT02028195
Other Study ID Numbers:
  • Tryg 7-11-0500
First Posted:
Jan 7, 2014
Last Update Posted:
Oct 1, 2018
Last Verified:
Sep 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Annelli Sandbæk, Professor, University of Aarhus
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 1, 2018